Experimental Renal and Cardiovascular Research, Department of Nephropathology Institute of Pathology and Department of Cardiology Friedrich‐Alexander‐University Erlangen‐Nürnberg 91054 Erlangen Germany
Auto-generated profile, based on publicly available information
Maren Fiedler
Experimental Renal and Cardiovascular Research, Department of Nephropathology Institute of Pathology and Department of Cardiology Friedrich‐Alexander‐University Erlangen‐Nürnberg 91054 Erlangen Germany
Biofabrication represents a promising technique for creating tissues for regeneration or as models for drug testing. Collagen-based hydrogels are widely used as suitable matrix owing to their biocompatibility and tunable mechanical properties. However, one major challenge is that the encapsulated cells interact with the collagen matrix causing construct shrinkage. Here, we present a hydrogel with high shape fidelity, mimicking the major components of the extracellular matrix. We engineered a composite hydrogel comprising gallic acid (GA)-functionalized hyaluronic acid (HA), collagen I, and HA-coated multiwall carbon nanotubes (MWCNT). This hydrogel supports cell encapsulation, exhibits shear-thinning properties enhancing injectability and printability, and importantly significantly mitigates shrinkage when loaded with human fibroblasts compared to collagen I hydrogels (∼20 % vs. > 90 %). 3D-bioprinted rings utilizing human fibroblast-loaded inks maintain their shape over 7 days in culture. Furthermore, inclusion of HAGA into collagen I hydrogels increases mechanical stiffness, radical scavenging capability, and tissue adhesiveness. Notably, the here developed hydrogel is also suitable for human induced pluripotent stem cell-derived cardiomyocytes and allows printing of functional heart ventricles responsive to pharmacological treatment. Cardiomyocytes behave similar in the newly developed hydrogels compared to collagen I, based on survival, sarcomere appearance, and calcium handling. Collectively, we developed a novel material to overcome the challenge of post-fabrication matrix shrinkage conferring high shape fidelity.
Bioprinting technology has attracted significant attention in the field of tissue engineering, enabling the precise placement of cells, biomaterials, and biomolecules to construct 3D tissue and organ structures. This review explores the feasibility of bioprinting functional organs by assessing current advancements in the field. A poll conducted among people from diverse backgrounds reveals common optimism regarding the future of organ bioprinting and its role in medicine and other fields. The article is conceptualized from a student‐to‐student perspective to provide a brief overview of key aspects of bioprinting, including bioinks, crosslinking techniques, bioprinting methods, and the maturation process required to develop functional tissues. Furthermore, it highlights recent progress in printing specific tissues as models for studying healthy and diseased tissues as well as implantable grafts. While there are still significant challenges that require the integration of technologies from engineering, biomaterials science, cell biology, physics, and medicine, ongoing research continues to address these complexities. The possibilities of bioprinting tissues and organs go beyond minimizing dependence on animal testing and advancing drug discovery; indeed, this approach also opens the door to accessible personalized medicine and presents a viable solution to the worldwide organ donor shortage.